Nuvectis Pharma Inc. Gains 20.52%
Thu, May 05, 2022 at 05:30 PM
Nuvectis Pharma Inc. (NVCT:NASDAQ) rocketted at $13.98, representing a gain of 20.5%. The stock appeared on our News Catalysts scanner on Wed, Apr 13, 2022 at 10:02 AM in the 'BIOTECH' category. From Thu, Apr 21, 2022, the stock recorded 33.33% Up Days and 50.00% Green Days
About Nuvectis Pharma Inc. (NVCT:NASDAQ)
Nuvectis Pharma Inc is a biopharmaceutical company.
Top 10 Gainers:
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 29.41%
- Hudson Technologies, Inc. (HDSN:NASDAQ), 26.89%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 25.04%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 21%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 20.52%
- Elevation Oncology Inc. (ELEV:NASDAQ), 19.67%
- Sonim Technologies, Inc. (SONM:NASDAQ), 19.2%
- AxoGen, Inc. (AXGN:NASDAQ), 18.28%
- Cyngn Inc. (CYN:NASDAQ), 17.98%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 17.19%